Intelligence · Patents
Patents expiring in 2031
Annual patent cliff calendar for 2031 — US pharmaceutical patents by expiration date.
- Patents
- 902
Quick answer
902 indexed pharmaceutical patents have expiration dates in 2031. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7928237
Fused ring azadecalin glucocorticoid receptor modulators
granted -
US 7928217
Nuclease resistant double-stranded ribonucleic acid
granted -
US 7927613
Pharmaceutical co-crystal compositions
granted -
US 7928244
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
granted -
US 7928079
Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
granted -
US 7927634
Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of Angelica sinensis, and methods of preparation thereof
granted -
US 7928213
Nucleic acids encoding chimeric CD154 polypeptides
granted -
US 7928194
Recombinant antigen for diagnosis and prevention of murine typhus
granted -
US 7928147
Antimicrobial wash and carrier solutions, and uses thereof
granted -
US 7928138
Marine actinomycete taxon for drug and fermentation product discovery
granted -
US 7928107
Quinazolines useful as modulators of ion channels
granted -
US 7928080
Indole antiviral compositions and methods
granted -
US 7928096
Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
granted -
US 7927833
Composition and method for enhancing immune response
granted -
US 7927821
Methods of screening for compounds which bind G protein-coupled receptors
granted -
US 7928062
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
granted -
US 7928105
Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones
granted -
US 7927793
Cell lines and host nucleic acid sequences related to infectious disease
granted -
US 7931640
Method for muscle delivery of drugs, nucleic acids and other compounds
granted -
US 7932382
Conformationally constrained Smac mimetics and the uses thereof
granted -
US 7932289
Remedy for diabetes
granted -
US 7932096
Trioxyethylene gold nanoclusters functionalized with a single DNA
granted -
US 7932052
Use of methanobactin
granted -
US 7932074
Multivalent human-bovine rotavirus vaccine
granted -
US 7931919
Method of producing glycine-stabilized, lyophilized plasma
granted -
CA 2708489
UTILISATION ANTITUMORALE NOUVELLE DU CABAZITAXEL
granted -
US 7935693
Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 7935796
Monoclonal antibodies against ANGPTL3
granted -
US 7935721
Spiro-oxindole compounds and their uses as therapeutic agents
granted -
US 7935357
Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species
granted -
US 7935351
Use of CPG oligodeoxynucleotides to induce angiogenesis
granted -
US 7935714
Compositions for sleeping disorders
granted -
US 7939635
Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
granted -
US 7937889
Green garlic and methods of production
granted -
US 7939263
Compositions and methods for treating and diagnosing cancer
granted -
US 7939304
Mutant MT-SP1 proteases with altered substrate specificity or activity
granted -
US 7939495
Method for improving skin conditions
granted -
US 7939689
Short-acting sedative hypnotic agents for anesthesia and sedation
granted -
US 7939639
Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology
granted -
US 7939558
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
granted -
US 7939468
Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents
granted -
US 7943131
Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists
granted -
US 7943148
Amino acid sites in Flavivirus E proteins useful for development of diagnostics and vaccines
granted -
US 7943770
Fused quinoline derivative and use thereof
granted -
US 7943141
Activated polyoxazolines and compositions comprising the same
granted -
US 7943137
FPRL1 ligands and use thereof
granted -
US 7943772
Crystalline forms of an 8-azabicyclo(3.2.1)octane compound
granted -
US 7943775
Small molecules for imaging protein-protein interactions
granted
Frequently asked questions
How many pharma patents expire in 2031?
902 published patents in our USPTO index have expiration dates falling in calendar year 2031.